Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Kedzierzyn-Kozle – page 2

17 clinical trials in Kedzierzyn-Kozle, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Kedzierzyn-Kozle at a glance
17
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

17 trials in Kedzierzyn-Kozle

Open in trial search

Cardiac failure acute

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Dapagliflozin
  • Sponsor:Medical University Of Warsaw
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Agencja Badań Medycznych
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Jtt-861 Monohydrochloride Dihydrate
  • Sponsor:Akros Pharma Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Merck Sharp & Dohme LLC

Cardiac failure+4

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cdr132L
  • Sponsor:Cardior Pharmaceuticals GmbH

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Kedzierzyn-Kozle

What the registry says about research in the country

01 Cardiovascular Disease Management

Groundbreaking research focusing on lipoprotein reduction and innovative therapies for patients with established cardiovascular disease. Studies aim to evaluate new treatments for reducing major cardiovascular events.

  • Cardiovascular death prevention
  • Non-fatal stroke management
  • Urgent coronary interventions

Trials utilize advanced therapeutic approaches to improve patient outcomes in cardiovascular care.

02 Heart Failure Research

Comprehensive studies examining SGLT-2 inhibitors and novel compounds for treating various forms of heart failure, including acute, chronic, and reduced ejection fraction conditions.

  • Acute heart failure treatment
  • Ejection fraction improvement
  • Kidney function optimization

Multiple therapeutic approaches are being evaluated to enhance patient care and survival rates.

03 Post-Myocardial Infarction Care

Innovative research investigating iron deficiency treatment and specialized therapies for patients recovering from myocardial infarction. Studies focus on improving mortality rates and quality of life.

  • Cardiovascular morbidity reduction
  • Quality of life enhancement
  • Heart failure prevention

Advanced therapeutic strategies are being tested to optimize recovery outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.